Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Fang Lv, Xiaoling Cai*, Chu Lin, Wenjia Yang, Suiyuan Hu, Linong Ji*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science